(Q27851860)

13 November 2016

title

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas (English)

1 reference

13 November 2016

0 references

1 reference

5

0 references

Marc Ladanyi

7

0 references

Mark G Kris

Mark G Kris

6

1 reference

ORCID Public Data File 2021

Gregory J Riely

8

Gregory J Riely

0 references

Camelia S Sima

2

Camelia S Sima

0 references

Jamie E Chaft

3

Jamie Chaft

0 references

author name string

Melissa L Johnson

1

0 references

Paul K Paik

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

4

0 references

language of work or name

English

0 references

publication date

15 January 2013

0 references

published in

Cancer

0 references

volume

119

0 references

issue

2

0 references

page(s)

356-62

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966555

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

2 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27730

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27730

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27730

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27730

Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22810899

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/22810899

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent

1 reference

https://pubmed.ncbi.nlm.nih.gov/22810899

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

0 references

1 reference

13 November 2016

1 reference